MATTHEWS TERENCE H 4
4 · COUNTERPATH CORP · Filed Jun 12, 2020
Insider Transaction Report
Form 4
COUNTERPATH CORPCPAH
MATTHEWS TERENCE H
DirectorChairman10% Owner
Transactions
- Purchase
Common Shares
2020-06-10$3.51/sh+142,451$500,003→ 1,649,112 total(indirect: Wesley Clover International Corporation)
Holdings
- 7,838.7
Deferred Share Units
From: 2010-06-18→ Common (3,000 underlying) - 4,838.7
Deferred Share Units
From: 2009-12-14→ Common (4,838.7 underlying) - 13,262.5
Deferred Share Units
From: 2013-07-25→ Common (2,262.5 underlying) - 16,689.9
Deferred Share Units
From: 2014-07-11→ Common (3,427.4 underlying) - 23,901.2
Deferred Share Units
From: 2015-07-17→ Common (7,211.3 underlying) - 1,506,661(indirect: Wesley Clover International Corporation)
Common Shares
- 9,460.3
Deferred Share Units
From: 2011-07-25→ Common (1,621.6 underlying) - 39,246.2
Deferred Share Units
From: 2016-07-14→ Common (15,345 underlying) - 83,157.2
Deferred Share Units
From: 2019-11-04→ Common (12,509 underlying) - 70,648.2
Deferred Share Units
From: 2018-07-26→ Common (14,459 underlying) - 11,000
Deferred Share Units
From: 2012-07-19→ Common (1,539.7 underlying) - 56,189.2
Deferred Share Units
From: 2017-07-14→ Common (16,943 underlying)
Footnotes (2)
- [F1]Dr. Matthews owns 99.999% of the issued and outstanding voting shares of Wesley Clover International Corporation.
- [F2]Each deferred share unit is convertible into one common share of CounterPath Corporation at no additional cost. There is no expiry date. The deferred share units vest immediately.